⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1341309 | 0.78 | FAAH (0.42) | — | |
| SCHEMBL15519857 | 0.78 | FAAH (0.42) | — | |
| SCHEMBL1327409 | 0.77 | — | — | |
| SCHEMBL3796966 | 0.76 | TSHR (0.46) | — | |
| SCHEMBL7648107 | 0.76 | TSHR (0.46) | — | |
| SCHEMBL25093190 | 0.76 | TSHR (0.46) | — | |
| SCHEMBL7049537 | 0.75 | PAOX (0.41) | — | |
| SCHEMBL277738 | 0.74 | — | — | |
| SCHEMBL1083082 | 0.69 | — | — | |
| SCHEMBL7049229 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1606019-A1 | CANNABINOID RECEPTOR INVERSE AGONISTS AND NEUTRAL ANTAGONISTS AS THERAPEUTIC AGENTS FOR THE TREATMENT OF BONE DISORDERS | The University Court of The University of Aberdeen (GB) | 2005-12-21 | — | — | EP | claimed |
| WO-2004078261-A1 | CANNABINOID RECEPTOR INVERSE AGONISTS AND NEUTRAL ANTAGONISTS AS THERAPEUTIC AGENTS FOR THE TREATMENT OF BONE DISORDERS | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2004-09-16 | — | — | WO | claimed |